Raymond James & Associates’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-8,647
| Closed | -$37K | – | 3217 |
|
|
2016
Q2 | $37K | Buy |
8,647
+400
| +5% | +$1.71K | ﹤0.01% | 2848 |
|
|
2016
Q1 | $46K | Buy |
+8,247
| New | +$46K | ﹤0.01% | 2756 |
|
|
2015
Q4 | – | Sell |
-10,297
| Closed | -$217K | – | 2464 |
|
|
2015
Q3 | $217K | Buy |
10,297
+300
| +3% | +$6.32K | ﹤0.01% | 2233 |
|
|
2015
Q2 | $495K | Sell |
9,997
-356
| -3% | -$17.6K | ﹤0.01% | 2088 |
|
|
2015
Q1 | $811K | Buy |
+10,353
| New | +$811K | ﹤0.01% | 1783 |
|
|
2014
Q3 | – | Sell |
-4,050
| Closed | -$250K | – | 2309 |
|
|
2014
Q2 | $250K | Sell |
4,050
-119
| -3% | -$7.35K | ﹤0.01% | 2099 |
|
|
2014
Q1 | $271K | Buy |
4,169
+155
| +4% | +$10.1K | ﹤0.01% | 1982 |
|
|
2013
Q4 | $226K | Sell |
4,014
-180
| -4% | -$10.1K | ﹤0.01% | 1922 |
|
|
2013
Q3 | $257K | Sell |
4,194
-116
| -3% | -$7.11K | ﹤0.01% | 1825 |
|
|
2013
Q2 | $252K | Buy |
+4,310
| New | +$252K | ﹤0.01% | 1767 |
|